
    
      Primary objective: To Evaluate the Safety and Tolerability of G-Pen™ (Glucagon Injection) 1
      mg

      Secondary objective (1): To Evaluate the pharmacodynamics (Efficacy) of G-Pen™ (Glucagon
      Injection) 1 mg

      Secondary objective (2):To compare the pharmacokinetics of G-Pen™ (glucagon injection) 1mg
      [test] administered as 0.5 mg and 1 mg injections, versus Lilly Glucagon™ (glucagon for
      injection [rDNA origin]) 1 mg (reference)
    
  